Resilient serial entrepreneur with over a decade of experience in the fields of digital health, quantitative and systems pharmacology (QSP), modeling and simulation in drug development, and building community with purpose, I am dedicated to improving self-healthcare through quantitative personalization that transcends access divides due to socio-economic factors. As the founder and CEO of DOX Health, Inc., I am building a highly scalable B2C2B platform, QPER Health, that provides users and patients with unprecedented access to tools, technologies, and knowledge to help them map and stay on track in their journey to better health. By leveraging data, analytics, and artificial intelligence, I aim to create personalized and predictive health solutions that optimize prescription and outcome for each individual. In addition to leading DOX Health, I also serve as an advisor for Ayma Therapeutics, a biotech company developing novel therapies for acute respiratory distress syndrome (ARDS), where I apply my expertise in modeling and simulation to support their clinical development. Furthermore, I am the founder, president, and co-organizer of Boston QSP, Inc., a non-profit organization that fosters the active sharing of QSP knowledge, challenges, solutions, and opportunities to advance the field as an interdisciplinary community in Boston. I am also the founder of Octet Research Inc., which provides modeling and simulation as services and consulting to bio-pharma and digital health companies.My mission is to empower patients and consumers to take charge of their own health. I am always eager to collaborate with other professionals and organizations who share my vision and values.